197 related articles for article (PubMed ID: 32686664)
21. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
22. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
Shi JA; Lu DL; Huang X; Tan W
Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
[TBL] [Abstract][Full Text] [Related]
23. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
24. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
Kahn SA; Wang X; Nitta RT; Gholamin S; Theruvath J; Hutter G; Azad TD; Wadi L; Bolin S; Ramaswamy V; Esparza R; Liu KW; Edwards M; Swartling FJ; Sahoo D; Li G; Wechsler-Reya RJ; Reimand J; Cho YJ; Taylor MD; Weissman IL; Mitra SS; Cheshier SH
Nat Commun; 2018 Oct; 9(1):4121. PubMed ID: 30297829
[TBL] [Abstract][Full Text] [Related]
25. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
[TBL] [Abstract][Full Text] [Related]
26. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
[TBL] [Abstract][Full Text] [Related]
27. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.
Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C
Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141
[TBL] [Abstract][Full Text] [Related]
28. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
Boon K; Eberhart CG; Riggins GJ
Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
[TBL] [Abstract][Full Text] [Related]
29. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
[TBL] [Abstract][Full Text] [Related]
30.
Kendall GC; Watson S; Xu L; LaVigne CA; Murchison W; Rakheja D; Skapek SX; Tirode F; Delattre O; Amatruda JF
Elife; 2018 Jun; 7():. PubMed ID: 29869612
[TBL] [Abstract][Full Text] [Related]
31. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
32. GFAP expression is regulated by Pax3 in brain glioma stem cells.
Su X; Liu X; Ni L; Shi W; Zhu H; Shi J; Chen J; Gu Z; Gao Y; Lan Q; Huang Q
Oncol Rep; 2016 Sep; 36(3):1277-84. PubMed ID: 27432276
[TBL] [Abstract][Full Text] [Related]
33. Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis.
Oristian KM; Crose LES; Kuprasertkul N; Bentley RC; Lin YT; Williams N; Kirsch DG; Linardic CM
Cancer Res; 2018 Oct; 78(19):5513-5520. PubMed ID: 30093562
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
35. β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.
Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgård R; Plate KH; Liebner S
Mol Cancer; 2015 Feb; 14(1):17. PubMed ID: 25645196
[TBL] [Abstract][Full Text] [Related]
36. The Expression of the Cancer-Associated lncRNA
Pensold D; Gehrmann J; Pitschelatow G; Walberg A; Braunsteffer K; Reichard J; Ravaei A; Linde J; Lampert A; Costa IG; Zimmer-Bensch G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572758
[TBL] [Abstract][Full Text] [Related]
37. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
[TBL] [Abstract][Full Text] [Related]
38. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
Bharambe HS; Paul R; Panwalkar P; Jalali R; Sridhar E; Gupta T; Moiyadi A; Shetty P; Kazi S; Deogharkar A; Masurkar S; Yogi K; Kunder R; Gadewal N; Goel A; Goel N; Chinnaswamy G; Ramaswamy V; Shirsat NV
Acta Neuropathol Commun; 2019 Apr; 7(1):52. PubMed ID: 30944042
[TBL] [Abstract][Full Text] [Related]
40. PAX3 silencing suppresses gastric cancer proliferation and angiogenesis via MET/PI3K signaling.
Lv WL; Hu YY; Li ZN; Zhang W; Pan Q
Neoplasma; 2020 Mar; 67(2):304-311. PubMed ID: 31847528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]